drugset / Trial / NCT05266417
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
This study will be evaluating the safety and efficacy of insulin and glutathione in subjects with Parkinson's Disease compared to placebo.
Timeline
- Start
- 2022-02-07
- Primary completion
- 2027-01-01
- Completion
- 2027-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glutathione | Peptide | — | Intranasal |
| Subject | Insulin | Protein / enzyme biologic | — | Intranasal |